Warning: You're using a guest account.
Unless you register as a full user all information associated with this session will be deleted within 24 hours.
LABEL: Genes Mutated in TNBC patient DESCRIPTION: This set describes actionable somatic mutations in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 7.5cm tumor from a 91 year old female patient. The tumor had characterisitcs of high-grade basal-like histology with tumor infiltrating lymphocytes, with angio-lymphatic invasion and lymph node metastasis, and low EGFR and absent CK5 expression respectively. Data from this sample are also in Gene Set #271950. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Mutated in TNBC patient DESCRIPTION: This set describes actionable somatic mutations in patients diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 4.6cm tumor from a 54 year old female patient. The tumor had characterisitcs of high-grade basal-like histology, angio-lymphatic invasion but no lymph-node metastasis, and high EGFR and high CK5 expression respectively. Data from this sample is also in Gene Set #271950. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes mutated in TNBC patient DESCRIPTION: This set describes somatic mutations in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 1.5cm tumor from a 44 year old female patient. The tumor had characterisitcs of high-grade histology, with angio-lymphatic invasion and lymph-node metastasis, with high EGFR and high CK5 expression respectively. Data from this sample is also in Gene Set #271951. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Mutated in TNBC patient DESCRIPTION: This set describes somatic mutations in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 4.7cm tumor from a 55 year old female patient. The tumor had characterisitcs of high-grade basal-like histology with tumor infiltrating lymphocytes, without angio-lymphatic invasion and lymph-node metastasis, and with high EGFR and high CK5 expression respectively. Data from this sample is also in Gene Set #271952. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Mutated in TNBC patient DESCRIPTION: This set describes somatic gene mutations in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 2.2cm tumor from a 45 year old female patient. The tumor had characterisitcs of high-grade basal-like histology, without angio-lymphatic invasion and without lymph-node metastasis, with low EGFR and high CK5 expression respectively. Data from this sample is also in Gene Set #271953. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Mutated in TNBC patient DESCRIPTION: This set describes somatic mutations in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 5cm tumor from a 40 year old female patient. The tumor had characterisitcs of high-grade basal-like histology, without angio-lymphatic invasion and without lymph node metastasis, and with high EGFR and high CK5 expression respectively. Data from this gene set is also in Gene Set #271954. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Mutated in TNBC patient DESCRIPTION: This set describes somatic mutations in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 6cm tumor from a 48 year old female patient. The tumor had characterisitcs of high-grade basal-like histology with tumor infiltrating lymphocytes, with angio-lymphatic invasion and lymph node metastasis, and with high EGFR and high CK5 expression respectively. Data from this gene set is also in Gene Set #271955. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Mutated in TNBC patient DESCRIPTION: This set describes somatic mutations in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 3.7cm tumor from a 53 year old female patient. The tumor had characterisitcs of high-grade histology with tumor infiltrating lymphocytes, without angio-lymphatic invasion, and with high EGFR and high CK5 expression respectively. Data from this sample is also in Gene Set #271956. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Mutated in TNBC patient DESCRIPTION: This set describes somatic mutations in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 0.9cm tumor from a 62 year old female patient. The tumor had characterisitcs of high-grade histology, without angio-lymphatic invasion and without lymph node metastasis, with high EGFR and high CK5 expression respectively. Data from this sample is also in Gene Set #271956. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes mutated in TNBC patient DESCRIPTION: This set describes somatic mutations in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 3cm tumor from a 63 year old female patient. The tumor had characterisitcs of high-grade histology and apocrine histologic features, with angio-lymphatic invasion but without lymph node metastasis, with high EGFR and high CK5 expression respectively. Data from this sample is also in Gene Set #271958. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes mutated in TNBC patient DESCRIPTION: This set describes somatic mutations in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 4cm tumor from a 55 year old female patient. The tumor had characterisitcs of high-grade histology and apocrine histologic features, with angio-lymphatic invasion,and with high EGFR and high CK5 expression respectively. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Mutated in TNBC patient DESCRIPTION: This set describes somatic mutations in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 1.8cm tumor from a 76 year old female patient. The tumor had characterisitcs of high-grade histology with tumor infiltrating lymphocytes, without angio-lymphatic invasion and without lymph-node metastasis, and with no EGFR and weak CK5 expression respectively. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Mutated in TNBC patient DESCRIPTION: This set describes somatic mutations in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 2.9cm tumor from a 30 year old female patient. The tumor had characterisitcs of high-grade basal-like histology with tumor infiltrating lymphocytes, without angio-lymphatic invasion and without lymph node metastasis, and with high EGFR and low CK5 expression respectively. Data from this sample is also in Gene Set #271961. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Mutated in TNBC patient DESCRIPTION: This set describes somatic mutations in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 7.5cm tumor from a 59 year old female patient. The tumor had characterisitcs of high-grade histology, with angio-lymphatic invasion and lymph node metastasis and high EGFR and low CK5 expression respectively. Data from this sample is also in Gene Set #271962. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Amplified in TNBC patient DESCRIPTION: This set describes somatic gene amplificationin a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 7.5cm tumor from a 91 year old female patient. The tumor had characterisitcs of high-grade basal-like histology with tumor infiltrating lymphocytes, with angio-lymphatic invasion and lymph node metastasis, and low EGFR and absent CK5 expression respectively. Additional data from this sample are reported in Gene Set #271935. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes amplified in TNBC patient DESCRIPTION: This set describes somatic gene amplification in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 1.5cm tumor from a 44 year old female patient. The tumor had characterisitcs of high-grade histology, with angio-lymphatic invasion and lymph-node metastasis, with high EGFR and high CK5 expression respectively. Data from the same sample are reported in Gene Set #271938. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Amplified in TNBC patient DESCRIPTION: This set describes somatic gene amplificationin a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 4.7cm tumor from a 55 year old female patient. The tumor had characterisitcs of high-grade basal-like histology with tumor infiltrating lymphocytes, without angiolymphatic invasion and lymph node metastasis, and with high EGFR and high CK5 expression respectively. Data from the same sample are described in Gene Set #271939. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Amplified in TNBC patient DESCRIPTION: This set describes somatic gene amplification in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 2.2cm tumor from a 45 year old female patient. The tumor had characterisitcs of high-grade basal-like histology, without angio-lymphatic invasion and without lymph-node metastasis, with low EGFR and high CK5 expression respectively. Data from this sample is also reported in Gene Set #271940. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Amplified in TNBC patient DESCRIPTION: This set describes somatic mutationsin a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 5cm tumor from a 40 year old female patient. The tumor had characterisitcs of high-grade basal-like histology, without angio-lymphatic invasion and without lymph node metastasis, and with high EGFR and high CK5 expression respectively. Data from this sample is also reported in Gene Set #271941. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Amplified in TNBC patient DESCRIPTION: This set describes somatic amplification in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 6cm tumor from a 48 year old female patient. The tumor had characterisitcs of high-grade basal-like histology with tumor infiltrating lymphocytes, with angio-lymphatic invasion and lymph node metastasis, and with high EGFR and high CK5 expression respectively. Data from this sample is also reported in Gene Set #271942. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Amplified in TNBC patient DESCRIPTION: This set describes somatic amplification in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 3.7cm tumor from a 53 year old female patient. The tumor had characterisitcs of high-grade histology with tumor infiltrating lymphocytes, without angio-lymphatic invasion, and with high EGFR and high CK5 expression respectively. Data from this sample is also reported in Gene Set #271943. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes amplified in TNBC patient DESCRIPTION: This set describes somatic gene amplification in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 3.1cm tumor from a 50 year old female patient. The tumor had characterisitcs of high-grade histology with tumor infiltrating lymphocytes, with angio-lymphatic invasion and lymph node metastasis, high EGFR and high CK5 expression respectively. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes amplified in TNBC patient DESCRIPTION: This set describes somatic gene amplification in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 3cm tumor from a 63 year old female patient. The tumor had characterisitcs of high-grade histology and apocrine histologic features, with angio-lymphatic invasion but without lymph node metastasis, with high EGFR and high CK5 expression respectively. Data from this sample is also in Gene Set #271945. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes amplified in TNBC patient DESCRIPTION: This set describes somatic gene amplification in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 3cm tumor from a 76 year old female patient. The tumor had characterisitcs of intermediate-grade histology, with angio-lymphatic invasion but without lymph node metastasis,and with high EGFR and high CK5 expression respectively. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes amplified in TNBC patient DESCRIPTION: This set describes somatic gene amplification in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 3cm tumor from a 76 year old female patient. The tumor had characterisitcs of intermediate-grade histology, with angio-lymphatic invasion but without lymph node metastasis,and with high EGFR and high CK5 expression respectively. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Amplified in TNBC patient DESCRIPTION: This set describes somatic gene amplification in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 2.9cm tumor from a 30 year old female patient. The tumor had characterisitcs of high-grade basal-like histology with tumor infiltrating lymphocytes, without angio-lymphatic invasion and without lymph node metastasis, and with high EGFR and low CK5 expression respectively. Data from this set is also in Gene Set #271948. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Amplified in TNBC patient DESCRIPTION: This set describes somatic gene amplification in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 7.5cm tumor from a 59 year old female patient. The tumor had characterisitcs of high-grade histology, with angio-lymphatic invasion and lymph node metastasis and high EGFR and low CK5 expression respectively. Data from this sample is also described in Gene Set #271949. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Amplified in TNBC patient DESCRIPTION: This set describes somatic gene amplification in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 6cm tumor from a 55 year old female patient. The tumor had characterisitcs of high-grade basal-like histology, without angio-lymphatic invasion but with lymph node metastasis, and high EGFR and no CK5 expression respectively. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Genes Amplified in TNBC patient DESCRIPTION: This set describes somatic mutations in a patient diagnosed with triple-receptor negative breast cancer. The data is reported in Table 1. This sample was a 2.3cm tumor from a 52 year old female patient. The tumor had characterisitcs of high-grade histology, with angio-lymphatic invasion and lymph node metastasis, and high EGFR and no CK5 expression respectively. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Clinically Actionable Mutations DESCRIPTION: This gene set summarizes figure 1 and represents the percentage of clinically actionable mutations detected in 20 tumors. The values represent the percentage of tumors with mutations. Gene symbols were converted to HGNC identifiers for data entry.
LABEL: Clinically Actionable Amplificat DESCRIPTION: This gene set summarizes figure 1 and represents the percentage of clinically actionable gene amplifications detected in 20 tumors. The values represent the percentage of tumors with mutations. Gene symbols were converted to HGNC identifiers for data entry.